Biomarkers of Disease and Response to Treatment in Opioid Addiction
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Naltrexone (Primary)
- Indications Drug dependence
- Focus Therapeutic Use
- 07 Aug 2017 Planned End Date changed from 1 Oct 2016 to 1 Oct 2018.
- 07 Aug 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2018.
- 07 Aug 2017 Status changed from recruiting to active, no longer recruiting.